Biopharmaceutical research companies are conducting or have conducted more than 550 clinical trials of new medicines in collaboration with the state’s clinical research centers, university medical schools and hospitals (1999 to present).
Of the more than 550 clinical trials, more than 300 target the nation’s six most debilitating chronic diseases—asthma, cancer, diabetes, heart disease, mental illnesses and stroke.
“This new report illustrates just how important it is to patients and our state’s economy to have had 568 industry-funded clinical trials of new medicines conducted in the state over the last 13 years. This cutting-edge research has helped to sustain jobs at research centers and hospitals in Portland, Biddeford, Brunswick, Sanford, Scarborough, Rockport, Bangor and other Maine communities." --Dana Connors, President, Maine Chamber of Commerce